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http://www.biomedcentral.com/1471-2180/13/155RESEARCH ARTICLE Open AccessPorphyromonas gingivalis downregulates the
immune response of fibroblasts
Eleonor Palm*†, Hazem Khalaf† and Torbjörn BengtssonAbstract
Background: Porphyromonas gingivalis is a key pathogen in periodontitis, an inflammatory disease leading to
destruction of bone and tooth-supporting tissue. P. gingivalis possesses a number of pathogenic properties to
enhance growth and survival, including proteolytic gingipains. Accumulating data shows that gingipains are
involved in the regulation of host inflammatory responses. The aim of this study was to determine if P. gingivalis
infection modulates the inflammatory response of fibroblasts, including the release of chemokines and cytokines.
Human gingival fibroblasts or primary dermal fibroblasts were pre-stimulated with tumor-necrosis factor-α (TNF- α)
and cocultured with P. gingivalis. Gingipain inhibitors were used to explore the effect of gingipains. CXCL8 levels
were determined with ELISA and the relative levels of various inflammatory mediators were determined by a
cytokine assay.
Results: TNF-α-triggered CXCL8 levels were completely abolished by viable P. gingivalis, whereas heat-killed P.
gingivalis did not suppress CXCL8. Accumulation of CXCL8 was partially restored by an arginine-gingipain inhibitor.
Furthermore, fibroblasts produced several inflammatory mediators, notably chemokines, all of which were
suppressed by viable P. gingivalis.
Conclusion: These findings provide evidence that fibroblast-derived inflammatory signals are modulated by
heat-instable gingipains, whereby the bacteria can escape killing by the host immune system and promote its own
growth and establishment. In addition, we show that fibroblasts are important mediators of inflammation in
response to infection and thereby play a crucial role in determining the nature and magnitude of the invasion of
immune cells.
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The gram-negative, anaerobic bacterium Porphyromonas
gingivalis is considered to be one of the key pathogens in
periodontitis, an inflammatory polymicrobial condition
leading to bone and tissue destruction and eventually
tooth loss [1]. Increasing evidence associate periodontitis
to systemic diseases [2] and for instance, P. gingivalis has
been found in atherosclerotic plaques [3,4] as well as in
non-healing ulcers (unpublished data). P. gingivalis pos-
sess a number of pathogenic properties to enhance growth
and survival such as fimbriae, lipopolysaccharides and
gingipains. The gingipains, which are grouped into lysine-
specific (Kgp) and arginine-specifik (Rgp) gingipains due* Correspondence: eleonor.palm@oru.se
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reproduction in any medium, provided the orto their specificity for cleavage after lysyl and arginyl resi-
dues, respectively, are cysteine proteases that have been
linked to the establishment and growth of P. gingivalis.
The gingipains are, like the fimbriae, important for the
bacterial invasion and colonization. They are reactive
against an array of different proteins, e.g. proteins of the
complement and kallikrein system, coagulation factors
and cytokines. Of particular interest, accumulating data
shows that gingipains are involved in the regulation of host
inflammatory responses. P. gingivalis stimulates an innate
immune response and induces expression of inflammatory
mediators, but can at the same time downregulate the host
response. In other words, P. gingivalis has evolved several
mechanisms to evade host immune system by invasion of
host cells and disrupting signalling pathways by cytokine
and receptor degradation [1,5-7].d. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Palm et al. BMC Microbiology 2013, 13:155 Page 2 of 9
http://www.biomedcentral.com/1471-2180/13/155Periodontitis is a chronic inflammation with associated
bone-resorption and tissue destruction. This degenerative
process is mainly a consequence of the hosts attempt to
eliminate the bacterial load rather than the bacteria them-
selves. As a consequence to bacterial encounter, the host
cells synthesize and release mediators attracting inflam-
matory cells to the site of infection, which in turn contrib-
ute to the characteristic tissue and bone destruction by
release of proteolytic enzymes, induction of osteoclast for-
mation and apoptosis of cells [1]. One important chemo-
kine that attracts neutrophils to the site of infection is
CXCL8. CXCL8 is expressed and produced by different
cell types, including fibroblasts, neutrophils, endothelial
cells, keratinocytes, epithelial cells and lymphocytes [8].
Innate immunity defence against invading pathogens
involves their sensing through highly conserved pattern
recognition receptors (PRRs). These receptors, including
toll like receptors (TLRs), are expressed by a variety of
cells, both immune and none-immune cells. For instance,
human gingival fibroblasts (HGFs) are likely to encounter
microbial invasion at an early stage of periodontitis and
interact with bacteria and bacterial products, and several
studies report a role of HGFs in periodontal inflammation
[9-11]. HGFs have been shown to express TLRs and, al-
though there are some inconsistencies in which TLRs that
are expressed, the importance of fibroblasts in innate im-
munity has started to be revealed. Mahanonda and col-
leagues reported that HGFs express functional TLR 2, 3, 4
and 5, and that ligand binding to these receptors lead to
the secretion of CXCL8 [12]. Uehara et al. demonstrated
that HGFs express TLR 1–9, and that stimulation of TLR
2/6, 3, 4, 7/8 and 9 caused production of several inflam-
matory mediators [13]. However, increasing data suggest
that fibroblasts are heterogeneous. Fibroblasts from differ-
ent anatomic sites, and even subpopulations of fibroblasts
from the same site, display distinct differences in morph-
ology, extracellular matrix production, migratory pheno-
type and cell surface antigens [14].
Recently, our group showed that P. gingivalis target T
cell derived interleukin (IL) 2 at the protein level and
suppresses activator protein 1, a mechanism by which P.
gingivalis benefits its own establishment by altering
adaptive immune responses [15]. The aim of the present
study is to characterize the effects of P. gingivalis on pri-
mary human fibroblasts and their derived inflammatory
responses, with the hypothesis that initial establishment
of P. gingivalis infection modulates immunoregulatory
mechanisms of fibroblasts.
Methods
Isolation and culture of fibroblasts
Primary human skin fibroblasts were isolated by explanting
pieces of dermis obtained from elective abdominal or chest
surgery from three young donors. The tissue was removedusing standard surgical procedures. Approval from the
local Ethical Committee at Örebro County Council,
Sweden, (no. 2003/0101), and informed consent was
obtained from each patient. Fibroblasts were propagated
from dermal preparations pieces by the explant tech-
nique. In brief, small pieces (half-millimeter) of dermis
were allowed to adhere to culture plastic for a few minutes
followed by addition of culture medium (Dulbecco’s modi-
fied Eagle medium (DMEM) supplemented with 10% fetal
bovine serum (FBS) and 1 mg/ml gentamicin (all from
Invitrogen Ltd, Paisley, UK). Gingival fibroblasts (HGF-1,
ATCC CRL-2014) were purchased from the American
Type Collection (Manassas, VA, USA). The fibroblasts
were cultured to confluence and removed from culture
plastic surface by incubation in 0.25% trypsin and 1 mM
EDTA (Invitrogen Ltd, Paisley, UK) at 37°C for 5 minutes.
The cells were plated in tissue culture flasks in DMEM
with 10% FBS. Fibroblasts were used at passages 3–10.Preparation of P. gingivalis
P. gingivalis ATCC 33277 (American Type Culture
Collection, Manassas, VA, USA) was cultured in fastidious
anaerobe broth (29.7 g/liter, pH 7.2) under anaerobic condi-
tions (80% N2, 10% CO2, and 10% H2) at 37°C in an anaer-
obic chamber (Concept 400 Anaerobic Workstation;
Ruskinn Technology Ltd., Leeds, United Kingdom). The
bacteria were harvested by centrifugation, washed and
resuspended in Krebs-Ringer glucose buffer (KRG)
(120 mM NaCl, 4.9 mM KCl, 1.2 mM MgSO4, 1.7 mM
KH2PO4, 8.3 mM Na2HPO4, and 10 mM glucose, pH 7.3).
Heat-killed P. gingivaliswas prepared by incubation at 70°C
for 1 h. To ensure that the bacteria were killed, 10 μl of the
heat-killed suspension was spread on a fastidious anaerobe
agar plate and incubated at 37°C for five days.Coculture of P. gingivalis and fibroblasts
In 0.5 ml DMEM supplemented with 10% FBS, primary
dermal fibroblasts from each subject or gingival fibro-
blasts were seeded with a density of 50,000 cells/well in
a 24-wells plate (Sarstedt, Inc, Newton NC, USA). After
24 hours, the fibroblasts were washed twice with phos-
phate buffered saline (PBS) (Invitrogen, Paisley UK) and
0.5 ml serumfree DMEM was added. After 24 hour of
starvation, the medium was replaced with DMEM
supplemented with 1% FBS. The cells were thereafter
treated with viable P. gingivalis, at a multiplicity of infec-
tion (MOI) of 1:1, 1:10, 1:100 or 1:1000, or heat-killed P.
gingivalis (MOI:1000). The cocultures were incubated
for 1, 6, or 24 hours in 37°C in 5% CO2.
CXCL8 accumulation was induced by pre-stimulating fi-
broblasts with tumor necrosis factor-α (TNF-α) (50 ng/ml)
for 6 hours prior to infection with P. gingivalis. The
fibroblasts were stimulated with the previously mentioned
Table 1 Cytokines, chemokines and acute phase proteins
that are detectable in the performed cytokine profiler
assay
C5a IL-4 IL-32α








IFN-γ IL-17E Serpin E1
IL-1ra IL-23 TNF-α
IL-2 IL-27 sREM-1
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ively, for 24 hours in 37°C in 5%CO2.
To evaluate the role of gingipains, P. gingivalis was
incubated with the Arg-gingipain inhibitor leupeptin
(Roche Diagnostics Corporation, Indiana, USA) or
the Lys-gingipain inhibitor cathepsin B inhibitor II
(Calbiochem, Biocompare, CA, USA), for 1 hour prior
to fibroblast stimulation. After stimulation with viable
and heat-killed P. gingivalis, and/or TNF-α, leupeptin as
well as cathepsin B inhibitor II, for 1, 6 or 24 hours, the
supernatants were collected and stored in aliquots at
−80°C prior to immunoassays.
FITC-labeling of P. gingivalis
P. gingivalis was washed three times with PBS by centrifu-
gation at 12000 rpm for three minutes, whereby the bac-
teria were resuspended in buffered saline (0.05 M Na2C03,
0.1 M NaCl, pH 9.3) containing 0.2 mg/ml fluorescein
isothiocyanate isomer (FITC) (Sigma-Aldrich, St. Louis,
MO, USA), and incubated in darkness at room-
temperature for 45 minutes. The bacteria were washed
in PBS prior to fibroblast infection.
Fluorescence microscopy
For fluorescence microscopy, fibroblasts were seeded on
coverslips in multiwell plates and incubated for 24 hours.
The fibroblasts were stimulated with FITC-labeled P.
gingivalis (MOI:100) for 6 hours. The cells were washed
twice with PBS, fixed with 4% paraformaldehyde (PFA)
for 30 min at room temperature and washed with PBS.
F-actin was visualized by incubating the cells with 2 units
Alexa Fluor® 594 phalloidin and 100 μg/ml lysophos-
phatidylcholine in darkness for 1 h at room temperature.
The nucleus was counterstained with 1 μg/ml 4′,6-
Diamidino-2-Phenylindole, Dihydrochloride (DAPI) for
2 min (all dyes obtained from Invitrogen Ltd, Paisley, UK).
Determination of cytokine production
CXCL8 was measured by Human IL-8 ELISA MAX De-
luxe Set (BioLegend San Diego, CA, USA) according to
the manufacturer’s instructions. All samples were run in
duplicates. For the parallel determination of the relative
levels of cytokines and chemokines, Human Cytokine
Array Panel A (R&D System, Inc, Abingdon, UK) was
performed according the manufacturer’s instructions.
Briefly, cell culture supernatants from representative ex-
periments were mixed with a cocktail of biotinylated de-
tection antibodies and the sample/antibody mixture was
incubated with the array where capture antibodies were
spotted in duplicate on a nitrocellulose membrane. Any
formed cytokine/detection antibody complex was then
bound by its immobilized capture antibody on the mem-
brane. Detection was performed by adding Streptavidin-
Horseradish Peroxidase and chemiluminescent detectionreagents, and the signal produced was in proportion to
the amount of cytokine bound. Chemiluminescence was
detected in the same manner as a Western blot (ChemiDoc
XRS System, Bio-Rad Laboratories, CA, USA). The array
determined the relative levels of 36 different cytokines,
chemokines and acute phase proteins (Table 1).
Data analysis
CXCL8 experiments were performed in three independ-
ent experiments (one experiment/primary fibroblast
strain) in duplicates to confirm the reproducibility of the
results. Experiments with human gingival fibroblasts
were performed in three independent experiments.
Statistical analysis with Student’s t-test was performed
using GraphPad Prism (GraphPad Software, La Jolla,
CA, USA). All data are presented as mean values with
standard deviation. A value of p < 0.05 was considered
statistically significant. One experiment was performed
for the cytokine array.
Results
P. gingivalis invades fibroblasts
The morphology of fibroblasts following treatment with
different concentrations of viable and heat-killed P.
gingivalis was examined by light microscopy. No obvious
morphological changes induced by the bacteria were ob-
served (data not shown). The interaction between P.
gingivalis and fibroblasts was visualized by fluorescence
microscopy. We found that P. gingivalis after 6 h effect-
ively adhered to and invaded the fibroblasts (Figure 1).
P. gingivalis affects the level of CXCL8 in a dose- and
time-dependent manner
Primary fibroblasts (50,000 cells/well) were stimulated
with different concentrations of viable P. gingivalis, as
well as heat-killed P. gingivalis, for 1 h, 6 h or 24 h
Figure 1 P. gingivalis adheres to and invades dermal fibroblasts. Dermal fibroblasts were seeded on a coverslip and incubated for 24 h. The
cells were then stimulated with FITC-labeled P. gingivalis (MOI:100) for 6 h. F-actin was visualized by incubating the cells with Alexa Fluor® 594
phalloidin (TRITC) and the nuclei were visualized by counterstaining the cells with DAPI. Magnification is 60× (Olympus FluoviewTM
FV1000, Germany).
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either viable or heat-killed P. gingivalis significantly
increased CXCL8 expression after short-term exposure
(1 h), whereas lower concentrations of viable P. gingivalis
(MOI:1, MOI:10, MOI:100) did not change the CXCL8
level compared to the unstimulated control. However,
long-term treatment (6 and 24 hours) with viable bacteria
(MOI:1000) resulted in a significant reduction in CXCL8
levels. Although not consistently statistically significant
for all concentrations of viable bacteria tested, there is a
tendency for decreasing CXCL8 levels with increasing
MOI. Heat-killed P. gingivalis (MOI:1000) resulted in ele-
vated CXCL8 production both after short- and long-term
exposure of fibroblasts.
P. gingivalis is involved in the degradation of CXCL8
protein
We thereafter aimed to determine if the decreased levels
of CXCL8, in response to viable P. gingivalis, were due
to protein degradation. The fibroblasts were pre-treated
with 50 ng/ml TNF-α for 6 hours to induce CXCL8
expression and accumulation. Thereafter, the fibroblasts
were incubated with viable P. gingivalis (MOI:1, 10, 100
and 1000) or heat-killed P. gingivalis (MOI:1000) for
24 hours. The fibroblasts synthesized high levels of
CXCL8 in response to TNF-α, which was furtherA B
Figure 2 P. gingivalis suppresses basal level CXCL8 accumulation. Prim
indicated concentrations of viable or heat-killed P. gingivalis (HK Pg, MOI:10
following short-term exposure (1 h), while long-term treatment (>6 h) supp
resulted in elevated CXCL8 expression both after short- and long-term trea
untreated negative control (C). *- p < 0.05; **- p < 0.01 (Student’s t-test).enhanced in the presence of viable P. gingivalis at
MOI:10. However, higher concentrations of viable
P. gingivalis (MOI:100 and MOI:1000), completely
abolished the TNF-α-induced accumulation of CXCL8
(Figure 3A). In contrast, however, heat-killed P.
gingivalis did not suppress TNF-α triggered CXCL8
levels (Figure 3B). These results were further con-
firmed by using gingival fibroblasts stimulated with vi-
able and heat-killed P. gingivalis, with and without
TNF-α pre-stimulation. CXCL8 basal levels were
suppressed by viable P. gingivalis and by heat-killed P.
gingivalis (Figure 3C). Furthermore, TNF-α-induced
CXCL8 expression was suppressed below basal levels
by viable bacteria, while heat-killed bacteria showed no
alteration in the pre-accumulated CXCL8 levels.
CXCL8 degradation is due to Arginine-gingipains
To determine if P. gingivalis suppresses TNF-α induced
CXCL8 release through Kgp and Rgp activities, viable P.
gingivaliswas incubated for 1 hour with increasing concen-
trations (0.1, 0.25, 0.5 and 1 mM) of cathepsin B II inhibitor
or Leupeptin, before fibroblast infection. The fibroblasts
were pre-stimulated with 50 ng/ml TNF-α for 6 hours and
then incubated for 24 hours with treated or non-treated P.
gingivalis. The Rgp inhibitor Leupeptin significantly re-
versed the P. gingivalis-induced suppression of CXCL8 atC
ary dermal fibroblasts (50,000 cells/well) were stimulated with the
00) for 1 h (A), 6 h (B) and 24 h (C). CXCL8 expression was increased
ressed CXCL8 accumulation. Heat-killed P. gingivalis treated fibroblasts
tment. The asterisks indicate significant differences compared to the
AC
B
Figure 3 P. gingivalis is involved in the degradation of CXCL8 protein. Dermal fibroblasts (50,000 cells/well) were stimulated with 50 ng/ml
TNF-α for 6 h, where after the cells were treated with either the indicated concentrations of viable P. gingivalis (A) or heat-killed P. gingivalis
(MOI:1000) (B) for 24 h. CXCL8 levels were significantly suppressed by viable, but not heat-killed, P. gingivalis. (C) Gingival fibroblasts were
stimulated with 50 ng/ml TNF-α for 6 h followed by treatment with viable or heat-killed P. gingivalis (MOI:100) for 24 h. Statistically significant
differences compared to the negative control (#) or positive control TNF-α (*) were determined using Student’s t-test (###/***- p < 0.001).
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hibitor at 1 mM only slightly changed the CXCL8 level
(Figure 4B).P. gingivalis targets a wide range of fibroblast-derived
inflammatory mediators
To examine if the immunomudulatory role of P. gingivalis
accounts for inflammatory mediators other than CXCL8,
a parallel determination of cytokines and chemokines
was performed with a cytokine array (Table 1). Primary
dermal fibroblasts (50,000 cells/well) were stimulated with
50 ng/ml TNF-α for 6 h before the cells were incubated
with viable or heat-killed P. gingivalis, (MOI:1000), re-
spectively (Figure 5). Non-stimulated fibroblasts were used
as a control. TNF-α alone, or in combination with heat-
killed P. gingivalis, induced secretion of TNF-α itself, as
well as serpin-1, IL-6, CCL2, CCL5, CXCL1, CXCL10 and
CXCL8. On the other hand, the levels of these inflamma-
tory mediators, except TNF-α and serpine-1, were mark-
edly suppressed by viable P. gingivalis. Heat-killed P.
gingivalis did not change the TNF-α induced expression
of the different inflammatory mediators, except an in-
hibition of CXCL10 and an enhancement (~ 2.5 fold) of
TNF-α. The level of serpine-1 was consistently expressedat high levels independently of stimulation with TNF-α
and/or bacteria.
Discussion
The aim of the present study was to characterize the ef-
fects of P. gingivalis on human fibroblast inflammatory
responses. The connection between periodontitis and
atherosclerosis, as well as other systemic diseases, has sug-
gested a role for periodontitis-induced bacteremia, includ-
ing P. gingivalis, in stimulating and maintaining a chronic
state of inflammation [2]. For instance, P. gingivalis DNA
has been detected in atherosclerotic plaques [3,4] and in
non-healing ulcers (unpublished data), however, to our
knowledge, no previous studies on P. gingivalis infection
of primary, human dermal fibroblasts have been per-
formed. The fibroblasts are a source of connective tissue
that maintain tissue haemostasis and integrity, and play an
important role in tissue generation after wounding as well
as in the pathogenesis of fibrotic inflammatory diseases
and excessive scarring involving extracellular matrix accu-
mulation [16]. Likewise, these cells have an active role in
the innate immunity, although the immunity properties of
fibroblasts have just begun to be revealed and many cha-
racteristics remain to be established [17,18]. In this study,
we show that human skin fibroblasts, as well as human
Figure 4 CXCL8 degradation is due to Arginine-gingipains. The involvement of Kgp and Rgp in CXCL8 degradation was determined by
using Cathepsin B inhibitor II and Leupeptin. Viable P. gingivalis were incubated with the indicated concentration of inhibitor for 1 h prior to
treatment of cells. Primary fibroblasts (50,000 cells/well) were stimulated with 50 ng/ml TNF-α for 6 h before the cells were incubated with P.
gingivalis for 24 h. CXCL8 accumulation was more efficiently restored by Leupeptin (A) than with Cathepsin B inhibitor II (B). The asterisks indicate
significant differences compared to cells treated with P. gingivalis, without inhibitor. *- p < 0.05 ***- p < 0.001 (Student’s t-test).
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immune system by sensing microbial invasion and re-
spond to it by producing and secreting inflammatory
mediators, notably chemokines. Furthermore, we demon-
strate that P. gingivalis has a direct modulatory function
of the immune response of fibroblasts through the cata-
lytic activities of gingipains targeting fibroblast-derived
inflammatory mediators at the protein level.
Fluorescent micrographs showed that viable P. gingivalis
adhered to and invaded dermal fibroblasts, suggesting that
P. gingivalis utilizes strategies to evade the host immune
response. This is in line with other studies that have
shown P. gingivalis adhesion and invasion of oralFigure 5 P. gingivalis targets a wide range of fibroblast-derived inflam
50 ng/ml TNF-α for 6 h before the cells were treated with viable, or heat-killed
possible detection of the cytokines and chemokines specified in Table 1. Cyto
instructions (A). Treatment with viable P. gingivalis resulted in degradation ofepithelial cells, mainly mediated by gingipains and
major fimbriae A. Invasion of epithelial cells, as well as
gingival fibroblasts, is probably a mechanism applied by
the bacteria to evade the host immune system and cause
tissue damage, an important part of the pathogenesis of
periodontitis [6,19,20]. For instance, this fimbriated
strain of P. gingivalis has previously been shown to in-
vade gingival epithelial cells after 90 minutes of incuba-
tion [21]. In this study we observed that P. gingivalis
invaded dermal fibroblasts and had established an infec-
tion after six hours of incubation. In addition, after six
hours of incubation was the CXCL8 level significantly
reduced by P. gingivalis.matory mediators. Fibroblasts (50,000 cells/well) were stimulated with
P. gingivalis (MOI:1000) for 24 h. The used cytokine array renders
kine and chemokine levels were determined according to manufacturer’s
all inflammatory mediators except TNF-α and Serpin-1 (B).
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that short-term exposure of viable or heat-killed P.
gingivalis (MOI:1000) induces CXCL8 production in fi-
broblasts. However, after 6 and 24 hours of incubation,
viable P. gingivalis suppressed basal CXCL8 accumula-
tion. On the contrary, heat-killed P. gingivalis increased
CXCL8 levels, indicating that P. gingivalis possess heat-
instable structures that are responsible for the degra-
dation of CXCL8. In correlation, previous studies have
shown that heat-killed P. gingivalis induces higher levels
of inflammatory mediators, in particular IL-6 and CXCL8,
than viable bacteria, suggesting degradation by the heat-
instable gingipains [10,22]. To further investigate the
effect of P. gingivalis on CXCL8, the fibroblasts were pre-
stimulated with TNF-α, a well known inducer of inflam-
matory mediators. Lower doses of viable P. gingivalis
(MOI:1 and MOI:10) in combination with TNF-α did not
alter CXCL8 levels when compared to the positive TNF-
α-stimulated control. However, higher concentrations
(MOI:100 and MOI:1000) completely abolished the TNF-
α-induced CXCL8 accumulation, while corresponding
concentration of heat-killed P. gingivalis (MOI:1000) did
not cause the same effects. This further implies that the
suppression of CXCL8 is due to the proteolytic capacities
of the gingipains. To test this theory and evaluate the im-
portance of gingipains, we used cathepsin B inhibitor II
and leupeptin, inhibitors of Kgp and Rgp, respectively. We
found that P. gingivalis-mediated degradation is mainly
dependent on Rgp. These findings are consistent with our
previous findings, as well as results from others, showing
that the gingipains from P. gingivalis degrades IL-2 and
CXCL8, respectively [8,15]. However, inhibition of Rgp
could only partially restore the CXCL8 levels, suggesting
involvement of other proteolytic enzymes. It is also pos-
sible that a combination of Rgp and Kgp has a synergistic
degradative effect, mediated by their specificity for cleav-
age after arginyl and lysyl residues, respectively. Further-
more, Dias and colleagues showed that there are two main
types of CXCL8, a 72 amino acid variant, secreted by
immune cells, and a 77 amino acid variant, secreted by
non-immune cells. The latter was shown to have a lower
chemotactic activity than the immune cell derived variant.
However, upon cleavage by gingipains this shifted, and the
77 amino acid variant increased the chemotactic activity
of neutrophils compared to the 72 amino acid variant [8].
Although gingipains degrade CXCL8, this consequently
suggests that the chemotactic activity of CXCL8 increases
upon stimulation of fibroblasts with P. gingivalis. How-
ever, more research is needed to determine the effects of
P. gingivalis-derived proteolytic enzymes on the activity of
these CXCL8 variants.
To investigate whether the gingipain-mediated effects of
P. gingivalis also include other fibroblast-derived inflam-
matory mediators, we performed a relative cytokine assaywhich measured various cytokines and chemokines. This
assay revealed that TNF-α stimulated primary, human
skin fibroblasts produce CXCL8, TNF-α, IL-6, CCL2,
CCL5, CXCL1 and CXCL10. Remarkably, the fibroblasts
produced mostly chemokines, indicating that fibroblasts
might play an important role as a link between the innate
and the acquired immunity. All TNF-α induced inflamma-
tory mediators, except TNF-α, were suppressed by viable
P. gingivalis, strongly suggesting an effect of the gingipains
per se. This shows that gingipains have a broad proteolytic
capacity and targets a wide array of cytokines and chemo-
kines, thereby interrupting several signaling pathways.
The chemokines CCL2, CCL5, CXCL1 as well as CXCL10
are all important for recruiting immune cells to the site of
infection, and by inhibiting their biological activity, P.
gingivalis is able to modulate and diminish the level of in-
filtrating immune cells.
In contrast, viable P. gingivalis was not able to suppress
TNF-α which is one of the most important inflammatory
mediators. In fact, the level of TNF-α increased nearly
two-fold by heat-killed bacteria, showing that P. gingivalis
induce TNF-α expression in fibroblasts and, at the same
time, degrade the TNF-α protein, although not exten-
sively. Periodontitis is associated with a decreased abun-
dance of fibroblasts [23] and TNF-α has been shown to be
an important mediator of P. gingivalis-induced apoptosis.
Graves et al. demonstrated that the numbers of apoptotic
fibroblasts were significantly reduced in the absence of the
TNF-receptor, suggesting that TNF-α-signalling is an im-
portant part in apoptosis of fibroblasts [24]. Thus, our re-
sults may indicate that P. gingivalis stimulates apoptosis of
fibroblasts through a less extensive degradation of TNF-α
and this could account for the fibroblast apoptosis that is
a distinctive feature of periodontitis. Nevertheless, the de-
gree of apoptotic fibroblasts after P. gingivalis infection
need to be further investigated. In addition, it has been
shown that the first nine residues of TNF-α N terminus
are not needed for TNF-α protein to exhibit its biological
activity [25]. Calkins and colleagues demonstrated that the
two types of gingipains are able to individually degrade
TNF-α, and also eliminate the biological activity [26].
CXCL10 is a chemokine with pleiotropic functions. It
works as a chemoattractant for its CXCR3 (CXCL10 re-
ceptor) positive cells such as T cells, eosinophils, mono-
cytes and NK cells, and it has also the capacity to induce
apoptosis and regulate cell growth and proliferation, as
well as angiogenesis [27,28]. Of interest, CXCL10 was
the only chemokine that was suppressed by heat-killed
as well as viable P. gingivalis, indicating that this chemo-
kine is regulated by some additional mechanism beside
that of heat-instable gingipains. For instance, a study by
Ohno et al. showed that CXCL10 and CCL5 gene is in-
duced by P. gingivalis in osteoblasts and ST2 mouse
stromal cells and that NFκB inhibitor suppressed CCL5
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gingivalis modulates CXCL10 gene expression through
an NFκB-independent pathway. Of further interest, the
expression of CXCL10 is increased in autoimmunity
diseases like rheumatoid arthritis and multiple sclerosis.
For instance, Lee et al. reported that CXCL10 contrib-
utes to bone-resorption by inducing osteoclast formation
in rheumatoid arthritis via induction of receptor activa-
tor of NFκB ligand (RANKL) [27]. However, since bone-
resorption is a hallmark of progressive periodontitis, our
results may indicate that CXCL10 plays a minor role
when it comes to bone-resorption since even heat-killed
P. gingivalis totally suppressed CXCL10. Besides, high
levels of CXCL10 have receptor-independent anti-
microbial properties. Even though it is questionable if
such high levels (about 1 μM), i.e. concentrations 100-
fold higher than needed for chemotactic function, are
realistic in vivo, Prost and colleagues showed that this
antimicrobial activity is achievable in vitro and may be
an important response against bacterial infection [30].
Thus, the strong suppressive effect of CXCL10 by both
viable and heat-killed P. gingivalis may in this case be
beneficial for a sustained P. gingivalis infection. Anyway,
further research is needed about the regulation of
CXCL10 and its signaling pathways as well as its role in
bacterial infection.
Serpin-1 (also known as plasminogen activator inhibitor
1), was continuously expressed regardless of stimulation
with TNF-α and/or bacteria. Serpin-1 plays an integrated
part of the plasmin system, working as an inhibitor of
tissue plasminogen activator as well as urokinase plasmi-
nogen activator, both of which converts plasminogen to
plasmin. Interestingly, serpin-1 has been implicated in
fibroblast senescent. Serpin-1 is induced by various
growth factors and has been suggested to be a down-
stream target of p53, where p53 controls growth factor-
dependent proliferation by upregulating serpin-1 [31].
However, the fibroblast strains in our experiments were
used at low passages.Conclusion
In conclusion, our results show that a broad range of
fibroblast-derived inflammatory mediators are inactivated
by P. gingivalis due to proteolytic activities of gingipains,
whereby the bacteria can create a more favourable milieu
where it can evade the host immune system and promote
its own growth and establishment. Also, by differentially
regulate the inflammatory mediators, such as CXCL10 and
TNF-α, P. gingivalis may have an impact on the compos-
ition of inflammatory cells infiltrate and the inflammatory
process itself. Increased understanding of the role of fibro-
blasts in innate and acquired immunity and their inter-
action with periodontal bacteria is crucial for developingnew strategies for preventing and treating periodontitis and
related chronic inflammatory diseases.
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